FDA Compliance 2012 - Verification and Validation Planning Under U.S. FDA cGMP, ICH Q9 and ISO 14971
Date2012-01-24
Deadline2012-01-24
VenuePalo Alto, USA - United States
KeywordsRisk Based Verification and Validation; FDA GMP Requirements; ICH Q9; ISO 14971 Requirements
Topics/Call fo Papers
This 90-minute Verification and Validation Planning training will cover "must have" elements from the U.S. FDA cGMP, ICH Q9 and ISO 14971 for hazard analysis and product risk management, and show how you can integrate these into a company's quality management system.
Why Should You Attend:
FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in big name device and pharma companies. And now the FDA is taking an even tougher stance. One major failing is lack of sufficient or targeted risk-based V&V planning. Why do companies need a Master Validation Plan? What are the must have elements from ISO 14971 and ICH Q9 for hazard analysis and product risk management? How can these be integrated into a company's quality management system.
Other CFPs
- Major CGMP Issues for 2012 - Webinar by ComplianceOnline
- Preparing for FDA GCP Inspections ? Essentials for Sponsor Companies
- Safety Reporting in Clinical Trials: Are you Compliant with the Current FDA Rules?
- International Association for Media and Communication Research Academic Conference
- ICCM 2012 : 8th International Conference on Computing Technology and Information Management
Last modified: 2011-12-26 17:14:01